1-6 of 6
Inger Margulies
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal residual disease in hairy cell leukemia patients treated by BL22

Free
Eugeny Arons, Joel Sunshine, Tara Suntum, Inger Margulies, Lynn Sorbara, Mark Raffeld, Maryalice Stetler-Stevenson, Ira Pastan, Robert J. Kreitman
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): A51.
Published: 15 August 2014
View articletitled, Minimal residual disease in hairy cell leukemia patients treated by BL22
Journal Articles

Molecular distinctions between variant and classic hairy cell leukemia

Free
Eugeny Arons, Tara Suntum, Joel Sunshine, Anna Orthwein, Inger Margulies, Maryalice Stetler-Stevenson, Robert Kreitman
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19_Supplement): A34.
Published: 15 August 2014
View articletitled, Molecular distinctions between variant and classic hairy cell leukemia
Journal Articles

Minimal Residual Disease in Hairy Cell Leukemia Patients Assessed by Clone-Specific Polymerase Chain Reaction

Free
Evgeny Arons, Inger Margulies, Lynn Sorbara, Mark Raffeld, Maryalice Stetler-Stevenson, Ira Pastan, Robert J. Kreitman
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (9): 2804–2811.
https://doi.org/10.1158/1078-0432.CCR-05-2315
Published: 04 May 2006
View articletitled, Minimal Residual Disease in Hairy Cell Leukemia Patients Assessed by Clone-Specific Polymerase Chain Reaction
Open the PDF for Minimal Residual Disease in Hairy Cell Leukemia Patients Assessed by Clone-Specific Polymerase Chain Reaction in another window
Journal Articles

Improved Cytotoxic Activity toward Cell Lines and Fresh Leukemia Cells of a Mutant Anti-CD22 Immunotoxin Obtained by Antibody Phage Display

Free
Giuliana Salvatore, Richard Beers, Inger Margulies, Robert J. Kreitman, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 995–1002.
Published: 01 April 2002
View articletitled, Improved Cytotoxic Activity toward Cell Lines and Fresh Leukemia Cells of a Mutant Anti-CD22 Immunotoxin Obtained by Antibody Phage Display
Open the PDF for Improved Cytotoxic Activity toward Cell Lines and Fresh Leukemia Cells of a Mutant Anti-CD22 Immunotoxin Obtained by Antibody Phage Display in another window
Journal Articles

Cytotoxic Activity of Disulfide-stabilized Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) toward Fresh Malignant Cells from Patients with B-Cell Leukemias

Free
Robert J. Kreitman, Inger Margulies, Maryalice Stetler-Stevenson, Qing-Cheng Wang, David J. P. FitzGerald, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (4): 1476–1487.
Published: 01 April 2000
View articletitled, Cytotoxic Activity of Disulfide-stabilized Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) toward Fresh Malignant Cells from Patients with B-Cell Leukemias
Open the PDF for Cytotoxic Activity of Disulfide-stabilized Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) toward Fresh Malignant Cells from Patients with B-Cell Leukemias in another window
Journal Articles

Hairy Cell Leukemia, a B-Cell Neoplasm That Is Particularly Sensitive to the Cytotoxic Effect of Anti-Tac(Fv)-PE38 (LMB-2)

Free
David H. Robbins, Inger Margulies, Maryalice Stetler-Stevenson, Robert J. Kreitman
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (2): 693–700.
Published: 01 February 2000
View articletitled, Hairy Cell Leukemia, a B-Cell Neoplasm That Is Particularly Sensitive to the Cytotoxic Effect of Anti-Tac(Fv)-PE38 (LMB-2)
Open the PDF for Hairy Cell Leukemia, a B-Cell Neoplasm That Is Particularly Sensitive to the Cytotoxic Effect of Anti-Tac(Fv)-PE38 (LMB-2) in another window